{"name":"Marina F Fahmy, MD","slug":"marina-f-fahmy-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ACTIVA KIDS bioactive restorative material","genericName":"ACTIVA KIDS bioactive restorative material","slug":"activa-kids-bioactive-restorative-material","indication":"Pediatric dental caries restoration","status":"phase_3"},{"name":"Fuji IX EXTRA","genericName":"Fuji IX EXTRA","slug":"fuji-ix-extra","indication":"Phase 3 clinical trials for Fuji IX EXTRA are ongoing, but specific indications are not publicly available.","status":"phase_3"}]}],"pipeline":[{"name":"ACTIVA KIDS bioactive restorative material","genericName":"ACTIVA KIDS bioactive restorative material","slug":"activa-kids-bioactive-restorative-material","phase":"phase_3","mechanism":"ACTIVA KIDS is a bioactive restorative material that promotes remineralization and biocompatibility in pediatric dental applications.","indications":["Pediatric dental caries restoration","Dentin remineralization in primary and permanent teeth"],"catalyst":""},{"name":"Fuji IX EXTRA","genericName":"Fuji IX EXTRA","slug":"fuji-ix-extra","phase":"phase_3","mechanism":"Fuji IX EXTRA's mechanism is not publicly available.","indications":["Phase 3 clinical trials for Fuji IX EXTRA are ongoing, but specific indications are not publicly available."],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}